Elisabeth M Paietta

Elisabeth M Paietta

UNVERIFIED PROFILE

Are you Elisabeth M Paietta?   Register this Author

Register author
Elisabeth M Paietta

Elisabeth M Paietta

Publications by authors named "Elisabeth M Paietta"

Are you Elisabeth M Paietta?   Register this Author

25Publications

911Reads

13Profile Views

Inhibition of the mutated c-KIT kinase in AML1-ETO-positive leukemia cells restores sensitivity to PARP inhibitor.

Blood Adv 2019 Dec;3(23):4050-4054

Sol Sherry Thrombosis Research Center and Fels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2019000756DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963253PMC
December 2019

Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008.

J Clin Oncol 2016 10;34(29):3544-3553

Chezi Genzel and Jacob M. Rowe, Shaare Zedek Medical Center, Jerusalem, Israel; Chezi Ganzel, Dan Douer, and Martin S. Tallman, Memorial Sloan Kettering Cancer Center; Elisabeth M. Paietta, Montefiore Medical Center; Peter H. Wiernik, St. Luke's-Roosevelt Medical Center, New York, NY; Judith Manola and Ju-Whei Lee, Dana-Farber Cancer Institute, Boston, MA; Hugo F. Fernandez, H. Lee Moffitt Cancer Institute, Tampa, FL; Mark R. Litzow, Mayo Clinic, Rochester, MN; Selina M. Luger, University of Pennsylvania, Philadelphia, PA; Hillard M. Lazarus, University Hospitals Case Medical Center, Cleveland, OH; and Larry D. Cripe, Indiana University Cancer Center, Indianapolis, IN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.5892DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074349PMC
October 2016

A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia.

JCI Insight 2016 Jun;1(9)

Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/jci.insight.87323DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951094PMC
June 2016

Dynamics of leukemia stem-like cell extinction in acute promyelocytic leukemia.

Cancer Res 2014 Oct 31;74(19):5386-96. Epub 2014 Jul 31.

Division of Hematology and Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota. Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-14-1210DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184925PMC
October 2014

Anthracycline dose intensification in acute myeloid leukemia.

N Engl J Med 2009 Sep;361(13):1249-59

Department of Blood and Marrow Transplantation, Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa0904544DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480917PMC
September 2009

A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia.

Haematologica 2006 Aug 25;91(8):1105-8. Epub 2006 Jul 25.

Division of Hematology, Mayo Clinic College of Medicine, 200 First St. S.W., Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
August 2006